Canadian trial tests pill to fight monkeypox at home
NCT ID NCT05534165
Summary
This study is testing if an oral medication called tecovirimat helps people with monkeypox who are well enough to stay home. It will see if the drug helps skin lesions heal faster and is safe to use. The trial also aims to learn if large studies for monkeypox treatments can be successfully run in Canada.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
-
St. Paul's Hospital, BC Centre for Excellence in HIV/AIDS
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
Conditions
Explore the condition pages connected to this study.